Introducing Altium i10 and company founder Alan Montgomery
Altium i10 was established by Alan Montgomery, who, for over 10 years, has focused on the performance benefits that can be achieved by simulated altitude training – specifically through Intermittent Hypoxic Training (IHT). In developing Altium i10, Alan originally worked with a senior physiologist at Strathclyde University. An initial device prototype was created in July 2014 and the first group physiological testing of the device was carried out by 20 club level triathletes and cyclists during December 2014, through to January and February 2015 at the University of the West of Scotland. This produced strong performance results, and the current Altium i10 device was then commercialised through a partnership with specialist product design firm Filament PD.
Over the years, the development of Altium i10 has combined physiology, microbiology, product design engineering and Computational Fluid Dynamics (CFD). The result is a portable and cost effective altitude simulation device, with significant commercial potential in multiple markets. Initially focusing on the benefits afforded to endurance sport athletes (cyclists, triathletes, runners, etc), interest in Altium i10 has also come through areas as diverse as team sports (soccer, rugby, hockey), mountain climbing and free diving.
Altium i10 founder Alan Montgomery is an accountant and a Fellow of his Institute. He has held senior finance positions with a number of international brand companies, such as Stakis Leisure, Rank Xerox and Playtex. He was Head of Mergers & Acquisitions at Scottish & Newcastle Breweries; Finance Director of Ellermann Leisure (including the Belfry Golf Course and Hotel); Finance Director of Scottish Television; CEO of Glasgow Rangers FC and Head of Corporate Finance at Ernst & Young in Glasgow.
Altium i10 is advised by a team of experienced professionals including IP specialists at Murgitroyd & Co; a team of lawyers at Maclay Murray & Spens; product designers at Filament PD; market insight and category development by the team at MultiSport Research; and human performance insights by physiologists at the University of the West of Scotland (UWE) and Manchester Metropolitan University (MMU).
Craig Lynn is Co-founder/Director of Filament PD and visiting Product Design Engineering tutor at the Glasgow School of Art. Craig graduated with a MEng in Product Design Engineering in 2008. Having set up design consultancy Meso, alongside fellow directors Danny Kane and Gregor Aikman, Craig then formed Filament PD, ‘a product development agency for the new industrial revolution’. Craig and the Filament PD team have been a recipient of a world renowned Red Dot Design Award, and a ROCCO Innovation and Technology award in 2011 & 2012. With extensive input over the years, Craig and Filament PD have been integral to the design and ongoing development of Altium i10.
Dr Mathew Piasecki of Manchester Metropolitan University (MMU) is a neuromuscular physiology specialist and acts as a Physiology Consultant to Altium i10. Mathew holds a first class honours degree in Biomedical Science and a PhD in neuromuscular physiology, and currently works as a full-time Research Associate. His current primary research interests include peripheral and central skeletal muscle fatigue, the effects of life-long exercise on skeletal muscle motor unit remodelling, and the age-related changes in motor neuron discharge rate and transmission stability. Mathew is exploring research into the effects of hypoxic training on physical performance and resistance to fatigue; and a comparison of neuromuscular characteristics in endurance and power trained athletes.
Gary Roethenbaugh is a Market Consultant to Altium i10, helping to expand the business internationally. He is also the Managing Director of independent specialist research & consulting firm, MultiSport Research, which was founded in June 2010. Gary is a law graduate with over 20 years’ experience in commercial consulting & investigations, research and analysis. Gary previously worked in corporate recovery and investigations for global accountancy firm KPMG and in information security.
About Altium i10
Improving oxygen uptake is key to boost cardiovascular fitness. The Altium i10 device measures and reduces the oxygen concentration that the athlete breathes in. Over an initial period of 28 days, with an athlete using the device for one hour a day, every other day, the body adapts to improve oxygen flow to the muscles.
Based in Glasgow and officially launched in September 2015, at the Cycle Show in Birmingham, UK, Altium i10 has been making waves across the endurance sport community. The Altium i10 is currently being used by keen amateur athletes competing at age-group level, along with elite cyclists, runners and triathletes aiming for the Olympic Games, the IRONMAN World Championships and the pinnacle of their chosen international sport.
Brand ambassadors include: Rio qualifiers Callum & Derek Hawkins (marathon) and Hannah Miley (swimming); elite athletes Matty Hynes (running), British Half Marathon Champion Jessica Coulson, Charline Joiner (cycling); and amateur age group triathlon team the Hartree JETS.
Altium i10 is billed as ‘the performance edge you have been searching for’. It offers a way of physically stressing the body to simulate altitude without overloading the body. It is a convenient and alternative method to deliver the endurance benefits of being at altitude.
For more information on Altium i10, please visit www.altium-i10.com.